Global Lipid Disorder Treatment Market Size, Share, Revenue, Trends And Drivers For 2024-2033

The Business Research Company’s Lipid Disorder Treatment Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 20, 2024 /EINPresswire.com/ -- The lipid disorder treatment market size has grown rapidly in recent years. It will grow from $9.48 billion in 2023 to $10.69 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to an increase in the adoption of sedentary lifestyles, a rise in the working population, increased awareness regarding the disease and treatment, the increase in desk jobs, and the growth of familial combined hyperlipidemia incidence.

The lipid disorder treatment market size is expected to see rapid growth in the next few years. It will grow to $17.36 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growing cases of obesity and high cholesterol, an increase in the prevalence of cardiovascular diseases, the growing occurrence of high cholesterol causing heart diseases, a rise in the demand for safe and efficient treatments, and excessive consumption of alcohol and smoking. Major trends in the forecast period include technological advancements in drug development, product innovation, increased investments in business expansion, and clinical advancements.

Explore comprehensive insights into the global lipid disorder treatment market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=15600&type=smp

Impact Of Obesity And High Cholesterol On The Lipid Disorder Treatment Market
The growing cases of obesity and high cholesterol are expected to propel the growth of the lipid disorder treatment market going forward. Obesity is a condition characterized by excessive body fat accumulation, while high cholesterol refers to elevated levels of cholesterol in the blood, which pose significant health risks. Obesity and high cholesterol are on the rise due to unhealthy diets, sedentary lifestyles, genetic predispositions, and environmental influences. Lipid disorder treatment plays a pivotal role in controlling obesity and high cholesterol by combining pharmacological interventions with lifestyle modifications, weight management strategies, patient education, and multidisciplinary care.

Major Players and Market Trends
Major companies operating in the lipid disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Fresenius SE & Co. KGaA, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline Plc, Wockhardt Ltd., Eli Lilly and Company, Amgen Inc., Boehringer-Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Kaneka Corporation, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, Kowa Pharmaceuticals America Inc., Concord Biotech Limited, Biocon Ltd., Ranbaxy Laboratories Limited.

Innovative Products And Developments In The Management Of Lipid Disorders
Major companies operating in the lipid disorder treatment market are developing proprotein convertase subtilisin type 9 (PCSK9) inhibitors to address the need for more effective and targeted therapies in managing high cholesterol levels. PCSK9 inhibitors manage lipid disorders by enhancing the removal of LDL cholesterol from the bloodstream, thereby reducing the risk of cardiovascular events in high-risk patients.

Segments:
• By Drug Type: Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, Other Drugs • By Indication: Familial Combined Hyperlipidemia, Familial Defective Apolipoprotein B-100, Familial Dysbetalipoproteinemia, Familial Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia, Other Indications • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Geographical Insights: North America Leading the Market
North America was the largest region in the lipid disorder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Access the complete report for an in-depth analysis of the global lipid disorder treatment market: https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Lipid Disorder Treatment Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Lipid Disorder Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on lipid disorder treatment market size, lipid disorder treatment market drivers and trends, lipid disorder treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The lipid disorder treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Antiphospholipid Syndrome Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

Retinal Disorder Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Phospholipid Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/phospholipid-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Clinical Trial Management Systems Market Insights